The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8798-8807

  Lieber, Andre ^a   He, Cheng Yi ^a   Meuse, Leonard ^a   Schowalter, David ^a   Kirillova, Irina ^b   Winther, Brian ^a   Kay, Mark A ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; GADOLINIUM CHLORIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; VIRUS ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA SYNTHESIS; GENE EXPRESSION; GENE TRANSFER; INFLAMMATORY CELL; KUPFFER CELL; LIVER CELL; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINANT;

EID: 0030756389     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8798-8807.1997     Document Type: Article

References (53)

1. Andus, T., J. Bauer, and W. Gerok. 1991. Effects of cytokines on the liver. Hepatology 13:364-375.
2. Baeuerle, P., and D. Baltimore. 1996 NF-κB: ten years after. Cell 87:13-20.
3. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene xpression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
4. Bett, A. J., W. Haddara, L. Prevec, and F. L. Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91:8802-8806.
5. Boucher, R. C. 1996. Current status of CF gene therapy. Trends Genet. 12:81-84.
6. Bruder, J., and I. Kovesti. 1997. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-6 expression. J. Virol. 71:398-404.
7. Busam, K. J., A. Homfeld, R. Zawatzky, S. Kastner, J. Bauer, W. Gerok, and K. Decker. 1990. Virus-vs endotoxin-induced activation of liver macrophages. Eur. J. Biochem. 191:577-582.
8. Callery, M. P., T. Kamei, and W. Flye. 1990. Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. Arch. Surg. 125:36-41.
9. Cornell, R. P. 1985. Restriction of gut-derived endotoxin impairs DNA synthesis for liver regeneration. Am. J. Physiol. 249:R563-R569.
10. Cornell, R. P., B. L. Liljequist, and K. F. Bartizal. 1990. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology 11:916-922.
11. Decker, K. 1990. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192:245-261.
12. Deryckere, F., and H.-G. Burger. 1996. Tumor necrosis factor a induces the adenovirus early 3 promoter by activation of NF-κB. J. Biol. Chem. 47: 30249-30255.
13. Fitzgerald, M., E. Webber, J. Donovan, and N. Fausto. 1995. Rapid DNA binding by nuclear factor κB in hepatocytes at the start of liver regeneration. Cell Growth Differ. 6:417-427.
14. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651-1655.
15. Ginsberg, H. S., U. Lundholm-Beauchamp, R. L. Horswood, B. Pernis, W. S. Wold, R. M. Chanock, and G. A. Pronce. 1989. Role of the early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86:3823-3827.
16. Ginsberg, H. S. 1996. The ups and downs of adenovirus vectors. Bull. N. Y. Acad. Med. 73:53-58.
17. Gooding, L. R. 1994. Regulation of TNF-mediated cell death and inflammation by human adenovirus. Infect. Agents Dis. 3:106-115.
18. Hardonk, M. J., F. W. J. Dihkhuis, C. E. Hulstaert, and J. Koudstaal. 1992. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J. Leukocyte Biol. 52:296-302.
19. Ilan, Y., G. Droguett, N. R. Chowdhury, Y. Li, K. Sengupta, N. R. Thummala, A. Davidson, J. R. Chowdhuty, and M. S. Horwitz. 1997. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc. Natl. Acad. Sci. USA 94:2587-2592.
20. Ishiyama, H., M. Sato, K. Matsumura, M. Sento, K. Ogino, and T. Hobara. 1995. Proliferation of hepatocytes and attenuation from carbon tetrachloride hepatotoxicity by gadolinium chloride in rats. Pharmacol. Toxicol. 77:293-298.
21. Kay, M. A., P. Baley, S. Rosenberg, F. Leland, L. Fleming, K. Parker-Ponder, T. Liu, G. Darlington, W. Pokorny, and S. L. C. Woo. 1992. Expression of human a1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc. Natl. Acad. Sci. USA 89:89-93.
22. Kay, M. A., Q. Li, F. Leland, C. Toman, M. Finegold, and S. L. C. Woo. 1992. Hepatic gene therapy: persistent expression of human a1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3:641-647.
23. Kay, M. A., F. Graham, F. Leland, and S. L. C. Woo. 1995. Therapeutic serum concentrations of human a1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21:815-819.
24. Kay, M. A., A.-X. Holterman, L. Meuse, A. Gown, H. Ochs, P. S. Linsley, and C. B. Wilson. 1995. Long term hepatic adenovirus mediated gene expression in mice following CTLA4Ig administration. Nat. Genet. 11:191-197.
25. Kolls, J., K. Peppel, M. Silva, and B. Beutler. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91:215-219.
26. Kuzmin, A. I., M. J. Finegold, and R. C. Eisensmith. 1997. Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther. 4:309-316.
27. Li, Q., M. A. Kay, M. Finegold, L. D. Stratford-Perricaudet, and S. L. C. Woo. 1993. Assesment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4:403-409.
28. Lieber, A., M.-J. Vrancken-Peeters, L. Meuse, N. Fausto, J. Perkins, and M. A. Kay. 1995. Adenovirus mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus tranduction of hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:6210-6214.
29. Lieber, A., C.-Y. He, I. Kirillova, and M. A. Kay. 1996. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70:8944-8960.
30. Marianneau, P., A. Cardona, L. Edelman, V. Deubel, and P. Despres. 1997. Dengue virus replication in human hepatoma cells activates NF-κB which in turn induces apoptotic cell death. J. Virol. 71:3244-3249.
31. Noah, T. L., I. A. Wortman, P. Hu, M. W. Leigh, and R. C. Boucher. 1996. Cytokine production by cultured human bronchial epithelial cells infected with a replication-deficient adenoviral gene transfer vector or wild type adenovirus type 5. Am. J. Cell. Mol. Biol. 14:417-424.
32. Pessara, U., and N. Koch. 1990. Tumor necrosis factor a regulates expression of the major histocompatibility complex class II-associated invariant chain by binding of an NF-κB-like factor to a promoter element. Mol. Cell. Biol. 10:4146-4154.
33. Pfizenmaier, K., H. Wajant, and M. Grell. 1996. Tumor necrosis factor in 1996. Cytokine Growth Factor Rev. 3:271-277.
34. Rai, R. M., S. Q. Yang, C. McClain, C. L. Karp, A. S. Klein, and A. M. Diehl. 1996. Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats. Am. J. Physiol. 270:G909-G918.
35. Salkowski, C. A., R. Neta, T. A. Wynn, G. Strassmann, N. van Rooijen, and S. N. Vogel. 1995. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J. Immunol . 155:3168-3179.
36. Sambucetti, L. C., J. M. Cherrington, G. W. G. Wilkinson, and E. Mocarski. 1989. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:4251-4258.
37. Schowalter, D., and M. Kay. Unpublished data.
38. Schowalter, D. B., L. Meuse, C. B. Wilson, P. S. Linsley, and M. A. Kay. 1997. Constitutive expression of murine CTLA4Ig from recombinant adenovirus vector results in prolonged transgene expression. Gene Ther. 4:853-860.
39. Shimizu, H., K. Mitomo, T. Watanabe, S. Okamoto, and K. Yamamoto. 1990. Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory cytokines. Mol. Cell. Biol. 10:561-568.
40. Shiratori, Y., S. Hongo, Y. Hikiba, K. Ohmura, T. Nagura, K. Okano, Y. Komatsu, and M. Omata. 1996. Role of macrophages in regeneration of liver. Dig. Dis. Sci. 41:1939-1946.
41. Sparer, T. E., R. A. Tripp, D. L. Dillehay, T. W. Hermiston, W. S. M. Wold, and L. R. Gooding. 1996. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J. Virol. 70:2431-2439.
42. Teodora, J. G., and P. E. Branton. 1997. Regulation of apoptosis by viral gene products. J. Virol. 71:1739-1746.
43. Tsui, L. V., L. G. Guidotti, T. Ishikawa, and F. V. Chrisari. 1995. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. USA 92:12398-12402.
44. Vidal, S. M., D. Malo, K. Vogan, E. Skamene, and P. Gros. 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate for Beg. Cell 73:469-495.
45. Vrancken Peeters, M.-J., A. Lieber, J. Perkins, and M. A. Kay. 1996. A method for multiple portal vein infusions in mice: quantification of adenovirus-mediated hepatic gene transfer. BioTechniques 20:278-285.
46. Watson, J., K. Kelly, M. Largen, and B. A. Taylor. 1978. The genetic mapping of a defective LPS responsive gene on C3H/HeJ mice. J. Immunol. 120:422-424.
47. Wold, W. S. M. 1993. Adenovirus genes that modulate the sensitivity of virus infected cells to lysis by TNF. J. Cell. Biochem. 53:329-335.
48. Wolff, G., S. Worgall, N. van Rooijen, W.-R. Song, B.-G. Harvey, and R. G. Crystal. 1997. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J. Virol. 71:624-629.
49. Worgall, S., G. Wolff, E. Falk-Pedersen, and R. G. Crystal. 1997. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8:37-44.
50. Wrighton, C. J., R. Hofer-Warbinek, T. Moll, R. Eytner, F. H. Bach, and R. de Martin. 1996. Inhibition of endothelial cell activation by adenovirus-mediated expression of I-κBa, an inhibitor of the transcription factor NF-κB. J. Exp. Med. 183:1013-1022.
51. Yamada, Y., I. Kirillova, J. J. Peschon, and N. Fausto. 1997. Initiation of liver growth by tumor necrosis factor in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 94:1441-1446.
52. Yang, Y., F. A. Nunes, K. Berensci, E. E. Furth, E. Gonzol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
53. Yang, Y., G. Trinchieri, and J. M. Wislon. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:362-369.